2-amino-1,3,4-thiadiazole has been researched along with Carcinoma, Squamous Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engstrom, PF; Falkson, G; Haller, DG; Ryan, LM | 1 |
| Asbury, RF; Blessing, JA; Homesley, HD; Malfetano, J; Mortel, R | 1 |
1 trial(s) available for 2-amino-1,3,4-thiadiazole and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Phase II study of aminothiadiazole in advanced squamous cell carcinoma of the esophagus.
Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Evaluation; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Survival Rate; Thiadiazoles | 1991 |
1 other study(ies) available for 2-amino-1,3,4-thiadiazole and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Aminothiadiazole (NSC #4728) in patients with advanced cervical carcinoma. A phase II study of the Gynecologic Oncology Group.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Thiadiazoles; Uterine Cervical Neoplasms | 1987 |